APY antibody; ATOPY antibody; B lymphocyte antigen CD20 antibody; B Lymphocyte Cell Surface Antigen B1 antibody; B-lymphocyte antigen CD20 antibody; B-lymphocyte cell-surface antigen B1 antibody; B-lymphocyte surface antigen B1 antibody; B1 antibody; Bp 35 antibody; Bp35 antibody; CD 20 antibody; CD20 antibody; CD20 antigen antibody; CD20 receptor antibody; CD20_HUMAN antibody; CVID 5 antibody; CVID5 antibody; Fc epsilon receptor I beta chain antibody; Fc Fragment of IgE high affinity I receptor for beta polypeptide antibody; FCER1B antibody; High affinity immunoglobulin epsilon receptor subunit beta antibody; IgE Fc receptor subunit beta antibody; IGEL antibody; IGER antibody; IGHER antibody; LEU 16 antibody; Leu-16 antibody; LEU16 antibody; leukocyte surface antigen Leu 16 antibody; Leukocyte surface antigen Leu-16 antibody; Ly44 antibody; Membrane spanning 4 domains A1 antibody; Membrane spanning 4 domains subfamily A member 2 antibody; membrane-spanning 4-domains A1 antibody; Membrane-spanning 4-domains subfamily A member 1 antibody; MGC3969 antibody; MS4A1 antibody; MS4A2 antibody; S7 antibody
Description:
The recombinant antibody against MS4A1 was produced using the Recombinant Human MS4A1 protein as the immunogen. This antibody exists as a non-conjugated isotype hIgG1, Affinity-chromatography purified. This antibody has been validated on ELISA.